A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

In a new JAMA Dermatology study, scientists at King's College London found that changes in two parts of the genome work ...

Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Feb. 4, 2025 — Graying hair is a hallmark of aging, often considered an inevitable part of growing older. However, recent research suggests that luteolin, an antioxidant found in vegetables ...